Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/APTA stock hub

AIM/APTA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AIM/APTAis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
20.7M
London Stock Exchange AIM
Market data

Live price

Current market quote for this ticker.

Current price
AIM/APTA
In the news

Latest news · AIM/APTA

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-102.2
P25 -54.2P50 2.1P75 13.7
ROIC-56
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AIM/APTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
GBP
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United Kingdom
Country code
UK
Employees
30
Employees Change
-1%
Employees Change Percent
-3.23
Enterprise value
GBX 19.5M
Exchange
London Stock Exchange AIM
Financial currency
GBP
First seen
2026-05-10
Industry
Biotechnology
Isin
GB00BNRRP542
Last refreshed
2026-05-10
Market cap
GBX 20.7M
Price
GBX 0.6
Price currency
GBX
Rev Per Employee
45,933.33x
Sector
Healthcare
Sic
2836
Symbol
aim/APTA
Website
https://aptamergroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-11.87%
EV Earnings
-7.94x
EV/FCF
-10.4x
EV/Sales
14.18x
FCF yield
-9.06%
P/B ratio
9.2x
P/S ratio
15.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-188.32%
EBITDA Margin
-177.43%
Gross margin
48.77%
Gross Profit
GBX 672,000
Gross Profit Growth
16.06%
Gross Profit Growth Q
25.34%
Gross Profit Growth3 Y
39.04%
Gross Profit Growth5 Y
13.36%
Net Income
GBX -2.5M
Net Income Growth Years
2%
Pretax Margin
-189.19%
Profit Margin
-178.52%
Profit Per Employee
GBX -82,000
ROA
-40.16
ROCE
-109.8
ROE
-102.2
ROIC
-56.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr1y
62.22%
Cagr3y
-64.12%
EPS Growth Quarters
5
EPS Growth Years
2
Revenue Growth
13.42x
Revenue Growth Q
26.8x
Revenue Growth Quarters
1x
Revenue Growth Years
1x
Revenue Growth3 Y
17.02x
Revenue Growth5 Y
-4.69x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
GBX 0.34
Assets
GBX 3.7M
Cash
GBX 1.5M
Current Assets
GBX 2.8M
Current Liabilities
GBX 1.4M
Debt
GBX 333,000
Debt Equity
GBX 0.15
Debt FCF
GBX -0.18
Equity
GBX 2.3M
Interest Coverage
-57.67
Liabilities
GBX 1.5M
Long Term Assets
GBX 938,000
Long Term Liabilities
GBX 111,000
Net Cash
GBX 1.2M
Net Cash By Market Cap
GBX 5.76
Net Cash Growth
-9.74%
Net Debt Equity
GBX -0.53
Tangible Book Value
GBX 2M
Tangible Book Value Per Share
GBX 0
WACC
9.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.04
Inventory Turnover
8.11
Net Working Capital
GBX 155,000
Quick ratio
1.89
Working Capital
GBX 1.4M
Working Capital Turnover
GBX 0.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-125.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
62.16%
200-day SMA
0.82
3Y total return
-95.38%
50-day SMA
0.7
50-day SMA vs 200-day SMA
50under200
All Time High
157
All Time High Change
-99.62%
All Time High Date
2022-01-05
All Time Low
0.2
All Time Low Change
200%
All Time Low Date
2024-10-14
ATR
0.07
Beta
0.92
Beta1y
0.3
Beta2y
0.76
Ch YTD
-44.19
High
0.65
High52
1.57
High52 Date
2025-09-02
High52ch
-61.78%
Low
0.55
Low52
0.3
Low52 Date
2025-06-20
Low52ch
100%
Ma50ch
-13.73%
Price vs 200-day SMA
-26.65%
RSI
42.31
RSI Monthly
10.58
RSI Weekly
40.3
Sharpe ratio
0.92x
Sortino ratio
1.79
Total Return
-125.71%
Tr YTD
-44.19
Tr1w
-4%
Tr3m
-35.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -2.6M
Operating margin
-188.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
2,870,784,930%
Net Borrowing
-311,000
Shares Insiders
5.08%
Shares Institutions
47.34%
Shares Out
3,455,143,950
Shares Qo Q
31.32%
Shares Yo Y
125.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
GBX -2M
Average Volume
5,417,444.8x
Bv Per Share
0
CAPEX
GBX -14,000
Ch1w
-4
Ch1y
62.16
Ch3m
-35.14
Ch3y
-95.38
Ch6m
-27.27
Change
0%
Change From Open
-2.04
Close
0.6
Days Gap
2.08
Depreciation Amortization
150,000
Dollar Volume
647,601
Earnings Date
2026-03-30
EBIT
GBX -2.6M
EBITDA
GBX -2.4M
EPS
GBX -0
F Score
3
FCF
GBX -1.9M
FCF EV Yield
-9.62x
FCF Per Share
GBX -0
Financing CF
1,528,000
Fiscal Year End
June
Founded
2,008
Income Tax
GBX -147,000
Investing CF
-102,000
Is Primary Listing
1
Last Earnings Date
2025-10-17
Last Report Date
2025-12-31
Ma150
0.83
Ma150ch
-27.76%
Ma20
0.61
Ma20ch
-1.45%
Net CF
-439,000
Open
0.61
Position In Range
50
Ppne
318,000
Price Date
2026-05-08
Ptbv Ratio
10.33
Relative Volume
0.18x
Revenue
1,378,000x
SBC By Revenue
8.71x
Share Based Comp
120,000
Tax By Revenue
-10.67x
Tr6m
-27.27%
Volume
1,079,335
Z Score
-1.9
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AIM/APTA pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/APTA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+62.2%
S&P 500 1Y: n/a
3Y total return
-95.4%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns AIM/APTA?

Insider, institutional, and short-interest positioning.

Institutional ownership
+47.3%
Share of float held by funds and institutions
Insider ownership
+5.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+125.7%
Negative means the company is buying back shares.
Technical

AIM/APTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.3
Neutral momentum band
Price vs 200-day MA
-26.7%
50/200-day relationship not available
Beta (5Y)
0.92
Moves roughly with the market
Sharpe ratio
0.92
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AIM/APTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/APTA stock rating?

aim/APTA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/APTA analysis?

The full report lives at /stocks/aim/APTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/APTA?

The latest report frames aim/APTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/APTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

aim/APTA stock profile: metrics, valuation and analysis | StockMarketAgent.AI